Author: Peri, Anna Maria; Verna, Marta; Biffi, Stefano; Alagna, Laura; Longhi, Benedetta; Migliorino, Guglielmo Marco; Foresti, Sergio; Bandera, Alessandra; Rovelli, Attilio; Rizzari, Carmelo; Gori, Andrea; Colombini, Antonella
Title: Combination Antifungal Therapy for Invasive Mold Infections Among Pediatric Patients with Hematological Malignancies: Data from A Real-Life Case-Series Document date: 2019_9_5
ID: 1egushdn_32
Snippet: In a recent Italian multicenter study on 127 invasive fungal infections in hemato-oncological pediatric patients, up to 45/126 (36%) episodes were treated with antifungal combinations as initial therapy and the author speculates that this choice was driven by the more severe clinical conditions of these patients [19] . Furthermore, in the international multicenter observational cohort study by Wattier et al on 131 IMI in children affected by hema.....
Document: In a recent Italian multicenter study on 127 invasive fungal infections in hemato-oncological pediatric patients, up to 45/126 (36%) episodes were treated with antifungal combinations as initial therapy and the author speculates that this choice was driven by the more severe clinical conditions of these patients [19] . Furthermore, in the international multicenter observational cohort study by Wattier et al on 131 IMI in children affected by hematological neoplasms, first-line combination therapy was used in 53% of cases and, similar to our findings, it was mainly used in patients who were already receiving anti-mold prophylaxis possibly due to concerns about prophylaxis-induced resistance [5] .
Search related documents:
Co phrase search for related documents- antifungal combination and cohort study: 1, 2
- antifungal combination and combination therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- antifungal combination and fungal infection: 1, 2
- antifungal combination and line combination therapy: 1
- antifungal combination and multicenter study: 1
- clinical condition and cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- clinical condition and combination therapy: 1, 2, 3, 4
- clinical condition and fungal infection: 1
- clinical condition and initial therapy: 1
- clinical condition and multicenter study: 1, 2, 3, 4, 5, 6
- clinical condition and patient clinical condition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- clinical condition and pediatric patient: 1, 2
- cohort study and combination therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- cohort study and fungal infection: 1, 2, 3, 4, 5, 6, 7
- cohort study and initial therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- cohort study and line combination therapy: 1
- cohort study and multicenter study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- cohort study and pediatric patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- combination therapy and fungal infection: 1, 2
Co phrase search for related documents, hyperlinks ordered by date